The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study
Objective: To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G) for achieving pituitary gonadotropin suppression during a controlled ovarian stimulation (COS...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | F&S Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334124000771 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|